<sent id="29">  Countries like Brazil and Thailand could only structure their AIDS programs because the main ARV medicines were not protected by patents and could be cheaply imported and\/or locally produced . </sent> <sent id="30">  And the success of the Brazilian program derived complimentary concerns , as Renata Reis says : `` The survival rate is very high here , so access to new second line therapy drugs has critical importance for keeping HIV infection under control by overcoming the long term patient 's growing resistance to the ARV previous treatments '' . </sent> <sent id="31">  The prices of the second line ARVs threaten the sustainability of Brazilian universal drugs distribution policy , since they can not be locally manufactured as generics . </sent>